181 related articles for article (PubMed ID: 23299800)
1. The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis.
Nowrouzi A; Cheung WT; Li T; Zhang X; Arens A; Paruzynski A; Waddington SN; Osejindu E; Reja S; von Kalle C; Wang Y; Al-Allaf F; Gregory L; Themis M; Holder M; Dighe N; Ruthe A; Buckley SM; Bigger B; Montini E; Thrasher AJ; Andrews R; Roberts TP; Newbold RF; Coutelle C; Schmidt M; Themis M
Mol Ther; 2013 Feb; 21(2):324-37. PubMed ID: 23299800
[TBL] [Abstract][Full Text] [Related]
2. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
3. Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature.
Condiotti R; Goldenberg D; Giladi H; Schnitzer-Perlman T; Waddington SN; Buckley SM; Heim D; Cheung W; Themis M; Coutelle C; Simerzin A; Osejindu E; Wege H; Themis M; Galun E
Mol Ther; 2014 Jan; 22(1):59-68. PubMed ID: 23982166
[TBL] [Abstract][Full Text] [Related]
4. Assessing the potential for AAV vector genotoxicity in a murine model.
Li H; Malani N; Hamilton SR; Schlachterman A; Bussadori G; Edmonson SE; Shah R; Arruda VR; Mingozzi F; Wright JF; Bushman FD; High KA
Blood; 2011 Mar; 117(12):3311-9. PubMed ID: 21106988
[TBL] [Abstract][Full Text] [Related]
5. Preventing and exploiting the oncogenic potential of integrating gene vectors.
Modlich U; Baum C
J Clin Invest; 2009 Apr; 119(4):755-8. PubMed ID: 19348042
[TBL] [Abstract][Full Text] [Related]
6. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.
Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C
Mol Ther; 2005 Oct; 12(4):763-71. PubMed ID: 16084128
[TBL] [Abstract][Full Text] [Related]
7. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Rosas LE; Grieves JL; Zaraspe K; La Perle KM; Fu H; McCarty DM
Mol Ther; 2012 Nov; 20(11):2098-110. PubMed ID: 22990674
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
9. Viral Vectors: The Road to Reducing Genotoxicity.
David RM; Doherty AT
Toxicol Sci; 2017 Feb; 155(2):315-325. PubMed ID: 27803388
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.
Baum C; Kustikova O; Modlich U; Li Z; Fehse B
Hum Gene Ther; 2006 Mar; 17(3):253-63. PubMed ID: 16544975
[TBL] [Abstract][Full Text] [Related]
11. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity assay for gene therapy vectors in tumor prone Cdkn2a⁻/⁻ mice.
Montini E; Cesana D
Methods Enzymol; 2012; 507():171-85. PubMed ID: 22365774
[TBL] [Abstract][Full Text] [Related]
13. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.
Montini E; Cesana D; Schmidt M; Sanvito F; Bartholomae CC; Ranzani M; Benedicenti F; Sergi LS; Ambrosi A; Ponzoni M; Doglioni C; Di Serio C; von Kalle C; Naldini L
J Clin Invest; 2009 Apr; 119(4):964-75. PubMed ID: 19307726
[TBL] [Abstract][Full Text] [Related]
14. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.
Montini E; Cesana D; Schmidt M; Sanvito F; Ponzoni M; Bartholomae C; Sergi Sergi L; Benedicenti F; Ambrosi A; Di Serio C; Doglioni C; von Kalle C; Naldini L
Nat Biotechnol; 2006 Jun; 24(6):687-96. PubMed ID: 16732270
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
[TBL] [Abstract][Full Text] [Related]
17. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
[TBL] [Abstract][Full Text] [Related]
18. Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents.
Rittelmeyer I; Rothe M; Brugman MH; Iken M; Schambach A; Manns MP; Baum C; Modlich U; Ott M
Hepatology; 2013 Jul; 58(1):397-408. PubMed ID: 23258554
[TBL] [Abstract][Full Text] [Related]
19. Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.
Heim D; Cornils K; Schulze K; Fehse B; Lohse AW; Brümmendorf TH; Wege H
Oncogene; 2015 Jan; 34(3):364-72. PubMed ID: 24413083
[TBL] [Abstract][Full Text] [Related]
20. Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector.
Evans-Galea MV; Wielgosz MM; Hanawa H; Srivastava DK; Nienhuis AW
Mol Ther; 2007 Apr; 15(4):801-9. PubMed ID: 17299406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
